Search for Clinical Trial Results

Explore a wide range of ongoing clinical trials and research studies. Stay updated on the latest healthcare advancements and medical breakthroughs. Learn how you can participate in medical research to contribute to scientific progress

Adenosquamous Carcinoma of the Endometrium - 13 Studies Found

Status Study
Recruiting Study Name: Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Condition: Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Aden
Date: 2013-09-03
Interventions: Drug: Cabozantinib S-malate Gi
Active, not recruiting Study Name: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer
Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma
Date: 2012-07-15
Interventions: Biological: Dalantercept Given
Active, not recruiting Study Name: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma
Date: 2011-09-24
Interventions: Drug: Carboplatin Given IV
Active, not recruiting Study Name: Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer
Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma
Date: 2011-03-01
Interventions: Drug: Akt Inhibitor MK2206 Giv
Completed Study Name: Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma
Date: 2010-09-25
Interventions: Biological: Trebananib Given IV Other Names:
Completed Study Name: Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma
Date: 2010-05-27
Interventions: Drug: Cediranib Maleate Given
Completed Study Name: Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma
Date: 2009-11-10
Interventions: Other: Diagnostic Laboratory Biomarker Analysis
Active, not recruiting Study Name: Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma
Date: 2009-09-12
Interventions: Biological: Bevacizumab Given
Completed Study Name: Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma
Date: 2009-01-09
Interventions: Drug: Gemcitabine Hydrochloride Given IV Other Names
Active, not recruiting Study Name: Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer
Condition: Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Aden
Date: 2007-12-15
Interventions: Drug: Cisplatin Given IV or IP
Page 1 of 2
Next >>>